Recombinant human brain natriuretic peptide (Shanghai Jiao Tong University)

重组人脑利钠肽 (上海交通大学)

Report date: 2022/12/17 17:14:10

Base Information

Drug NameRecombinant human brain natriuretic peptide (Shanghai Jiao Tong University)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionNatriuretic peptide receptor 1 agonists
TargetsNatriuretic peptide receptor 1
Therapy Area/IndicationsTetralogy of FallotHeart Defects, Congenital
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesShanghai Jiaotong University
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Jiaotong University
Inactive CompaniesN/A
Active IndicationsTetralogy of FallotHeart Defects, Congenital
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A